FERRO, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 982
EU - Europa 481
AS - Asia 240
AF - Africa 37
OC - Oceania 1
Totale 1.741
Nazione #
US - Stati Uniti d'America 966
IT - Italia 199
CN - Cina 123
VN - Vietnam 96
NL - Olanda 95
GB - Regno Unito 51
DE - Germania 39
CI - Costa d'Avorio 36
IE - Irlanda 36
FI - Finlandia 22
CA - Canada 16
IN - India 14
SE - Svezia 12
UA - Ucraina 9
SG - Singapore 5
BE - Belgio 3
DK - Danimarca 3
LT - Lituania 3
FR - Francia 2
AT - Austria 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CH - Svizzera 1
ES - Italia 1
HR - Croazia 1
MA - Marocco 1
MT - Malta 1
NP - Nepal 1
TR - Turchia 1
Totale 1.741
Città #
Chandler 202
Ashburn 138
Dong Ket 96
Amsterdam 94
Naples 91
Beijing 47
Millbury 44
Enfield 41
Des Moines 36
Princeton 30
Boston 28
Nanjing 27
Lawrence 22
Napoli 18
Ottawa 16
Washington 16
Wilmington 14
Dearborn 10
Dublin 10
Frankfurt am Main 10
Phoenix 10
Hebei 9
Houston 7
Jiaxing 7
Kronberg 7
Pune 7
Seattle 7
Hanover 6
Jacksonville 6
Norwalk 6
Shenyang 6
Boardman 5
Changsha 5
Tianjin 5
Caserta 4
Council Bluffs 4
Milan 4
Nanchang 4
Redwood City 4
Rome 4
Siziano 4
Woodbridge 4
Cambridge 3
Dallas 3
Florence 3
Hefei 3
Marijampolė 3
Salerno 3
Wuhan 3
Augusta 2
Aversa 2
Cardiff 2
Courcelles 2
Fairfield 2
Falls Church 2
Forlì 2
Guangzhou 2
Kolkata 2
Lappeenranta 2
Locate di Triulzi 2
London 2
New York 2
Piana 2
Romainville 2
Rovereto 2
San Cipriano Picentino 2
Singapore 2
Agadir 1
Avellino 1
Benevento 1
Bitonto 1
Brussels 1
Bungarribee 1
Burgas 1
Castelnuovo Rangone 1
Cinisello Balsamo 1
Edinburgh 1
Fagnano Olona 1
Gragnano 1
Groningen 1
Grumo Nevano 1
Indiana 1
Kathmandu 1
Krefeld 1
Latina 1
Madrid 1
Manassas 1
Menlo Park 1
Mugnano di Napoli 1
Nürnberg 1
Orange 1
Osnago 1
Paderno Dugnano 1
Piacenza 1
Salento 1
Sarajevo 1
Sciacca 1
Somma Vesuviana 1
Stockholm 1
Toenisvorst 1
Totale 1.205
Nome #
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets 96
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials 51
Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer 50
Prostate health index vs percent free prostate-specific antigen for prostate cancer detection in men with "gray" prostate-specific antigen levels at first biopsy: Systematic review and meta-analysis 49
Epigenetic signature: A new player as predictor of clinically significant prostate cancer (PCa) in patients on active surveillance (AS) 46
Matrix metalloproteinase-2 and -9 in the urine of prostate cancer patients. 42
Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management-Current Trends and Future Perspectives 42
Effects of the ErbB1/ErbB2 kinase inhibitor GW2974 on androgen-independent prostate cancer PC-3 cell line growth and NSE, chromogranin A and osteopontin content. 41
Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis 39
Improving the prediction of pathologic outcomes in patients undergoing radical prostatectomy: the value of prostate cancer antigen 3 (PCA3), prostate health index (phi) and sarcosine 39
Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance 39
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study 38
Biomarkers in localized prostate cancer 37
Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomy 37
Preoperative insulin-like growth factor-binding protein-3 (IGFBP-3) blood level predicts gleason sum upgrading 36
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 36
Neutrophil, platelets, and eosinophil to lymphocyte ratios predict gleason score upgrading in low-risk prostate cancer patients 36
Modified glasgow prognostic score is associated with risk of recurrence in bladder cancer patients after radical Cystectomy: A multicenter experience 35
Soluble interleukin-6 receptor to interleukin-6 (sIL-6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy 34
Predicting pathological features at radical prostatectomy in patients with prostate cancer eligible for active surveillance by multiparametric magnetic resonance imaging 34
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 34
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer 33
Peri-Prostatic Adipocyte-Released TGFβ Enhances Prostate Cancer Cell Motility by Upregulation of Connective Tissue Growth Factor 33
Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients 31
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance 31
New Cross-Talk Layer between Ultraconserved Non-Coding RNAs, MicroRNAs and Polycomb Protein YY1 in Bladder Cancer 31
Periprostatic adipose tissue promotes prostate cancer resistance to docetaxel by paracrine IGF‐1 upregulation of TUBB2B beta‐tubulin isoform 31
Salvage radical prostatectomy after external beam radiation therapy: A systematic review of current approaches 30
The evolving role of monoclonal antibodies in the treatment of patients with advanced renal cell carcinoma: a systematic review 30
Circular RNAs: An emerging type of non-coding RNA and their potential implications in bladder cancer 30
Optimized Identification of High-Grade Prostate Cancer by Combining Different PSA Molecular Forms and PSA Density in a Deep Learning Model 30
The emerging role of obesity, diet and lipid metabolism in prostate cancer 29
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 29
Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade/grade 3 bladder cancer 29
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis 29
Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol 28
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer 28
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 28
SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study 28
Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study. 25
High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study 24
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 24
Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies 24
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy 24
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies 24
New strategy for the identification of prostate cancer: The combination of Proclarix and the prostate health index 23
Robot-assisted Partial Nephrectomy: 5-yr Oncological Outcomes at a Single European Tertiary Cancer Center 23
Urinary long noncoding RNAs in nonmuscle-invasive bladder cancer: new architects in cancer prognostic biomarkers 21
Subcellular Localization of uc.8+ as a Prognostic Biomarker in Bladder Cancer Tissue 21
The use of 68Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities 19
Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review 18
Patient Selection for Active Surveillance in the Multi-parametric Magnetic Resonance Imaging Era: A Step Forward in a Rapidly Evolving Field 18
Surgical blood loss during holmium laser enucleation of the prostate (HoLEP) is not affected by short-term pretreatment with dutasteride: a double-blind placebo-controlled trial on prostate vascularity 17
Urologic malignancies: advances in the analysis and interpretation of clinical findings 16
The Impact of Meat Intake on Bladder Cancer Incidence: Is It Really a Relevant Risk? 15
Circulating tumor cells in bladder cancer: a new horizon of liquid biopsy for precision medicine 15
Current Management of Urachal Carcinoma: An Evidence-based Guide for Clinical Practice 12
The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial 10
A Neural Network Model Combining [-2]proPSA, freePSA, Total PSA, Cathepsin D, and Thrombospondin-1 Showed Increased Accuracy in the Identification of Clinically Significant Prostate Cancer 7
Which inflammatory marker, between systemic immune-inflammation index and neutrophil to eosinophil ratio, is associated with Peyronie's disease and are there any implications for a better understanding of its mechanisms? 6
Management of the incidental adrenal mass, continued surveillance versus surgical excision: analysis of US claims data on contemporary socio-demographic predictors and perioperative outcomes 5
Micro-RNAs Predict Response to Systemic Treatments in Metastatic Renal Cell Carcinoma Patients: Results from a Systematic Review of the Literature 5
Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice 5
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG 4
Radiomics in prostate cancer: an up-to-date review 4
Bladder Cancer and Risk Factors: Data from a Multi-Institutional Long-Term Analysis on Cardiovascular Disease and Cancer Incidence 4
Molecular Imaging Diagnosis of Renal Cancer Using 99mTc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel Techniques 4
Radiogenomics in Renal Cancer Management-Current Evidence and Future Prospects 3
Novel Key Ingredients in Urinary Tract Health-The Role of D-mannose, Chondroitin Sulphate, Hyaluronic Acid, and N-acetylcysteine in Urinary Tract Infections (Uroial PLUS®) 3
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer 3
Inguinal lymphadenectomy in penile cancer patients: a comparison between open and video endoscopic approach in a multicenter setting 3
Contemporary trends in the surgical management of urinary incontinence after radical prostatectomy in the United States 2
Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer 2
Radiotherapy to the Primary Tumor: The First Step of a Tailored Therapy in Metastatic Prostate Cancer 2
Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review 1
Totale 1.865
Categoria #
all - tutte 7.744
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.744


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 4 5 0 0
2019/2020163 62 1 2 6 2 5 19 2 7 21 29 7
2020/2021190 7 1 4 1 6 11 2 1 31 16 5 105
2021/2022338 9 4 2 0 6 3 6 12 30 39 108 119
2022/2023657 54 25 24 19 77 64 4 52 84 177 72 5
2023/2024400 10 75 100 39 32 56 10 72 6 0 0 0
Totale 1.865